Business Standard

Nureca Share Price

Know More
NSEBSE

289.90-0.50 (-0.17%)

03:44 PM,12th Apr 2024

291.500.10 (0.03%)

04:01 PM,12th Apr 2024

BSE : 543264

NSE : NURECA

Sector : Others

ISIN Code : INE0DSF01015

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 12 2024 | 04:01 PM IST

Market Cap (₹ Cr)

289

Turnover (₹ Cr)

0.03

Volume (Shares)

10439

Face Value

10

52-WK High

468.80

52-WK High Date

26 Dec 2023

52-WK Low

253.50

52-WK Low Date

28 Mar 2024

All Time High

2315.00

All Time High Date

08 Oct 2021

All Time Low

253.50

All Time Low Date

28 Mar 2024

Nureca Ltd

The Company was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products. The Company is a leading healthcare and wellness company with a product range of over 150 SKUs across different categories. The flagship brands such as Dr. Trust continue to enjoy high credibility and a loyal customer base. The products comply with USFDA European CE ROHS and ISO certifications which reinforce customer's belief in their products. At present the Company holds more than 100 design products. Nureca is a digital first B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions helping users monitor chronic ailments. The Company is committed to creating products that support diagnosis treatment and prevention of illness through monitoring and analysis of health data. Nureca's products are manufactured to be safe accurate long-lasting and compliant with national and international regulations. The Company's growing range of connected devices is well entrenched in IoT and easy to sync with smart devices while health app provides secure consolidation of data.The Company is focused on leveraging its innovation research and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. The Company envisaged digital ecosystem and principles aims to provide integrated solutions aiding customers to maintain a suitable fitness regime have clear understanding of and control over existing diseaseswith easier health monitoring at home and optimum nutrition through quality nutraceuticals.In 2017 the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel.In 2018 the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab Karnataka and Uttar Pradesh. In 2019 the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh Telangana and Maharashtra. The Company's key products secured a warehouse drug license.In 2020 Company expanded presence through different channels and took initiative for starting business with 1mg Pharmeasy Paytm and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited (demerged company) and Nureca Private Limited (resulting company) and their respective shareholders and creditors under Section 230 to 232 and other applicable provisions of the Companies Act 2013 which has been sanctioned by the Honorable National Company Law Tribunal (NCLT) Mumbai vide its Order dated 29 April 2020. The Scheme had become effective on 23 May 2020 (Effective date) on filing of certified copy of the Order with the Registrar of Companies. The Appointed Date from which the Scheme was operative was 1 April 2019. Pursuant to the Scheme of Demerger certain portion of business activities of the demerged company was transferred by Nectar Biopharma Private Limited from the Appointed date of 1 April 2019.In FY 2021 the Company received prestigious 'Economic Times Best Healthcare Brands Award 2021'.

Nureca Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

289

EPS - TTM (₹) [C]

0.82

P/E Ratio (X) [C]

1.47

Face Value (₹) 10
Latest Dividend (%)30.00
Latest Dividend Date 24 Feb 2022
Dividend Yield (%) -
Book Value Share (₹) [C]197.04
P/B Ratio (₹) [C]1.47
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 31 0.01

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

288.05

293.30

Week Low/High

288.05

299.00

Month Low/High

253.50

328.00

Year Low/High

253.50

469.00

All time Low/High

252.40

2315.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.14%-1.34%0.000.03%
1 Month-6.74%-6.60%0.780.82%
3 Month-29.56%-29.60%2.312.85%
6 Month-18.80%-18.82%11.8013.77%
1 Year-14.56%-14.42%22.9426.43%
3 Year-68.74%-68.88%55.0557.36%

Company Info

Company Information

Independent Director : Vijay Kumar Sharma

Independent Director : Charu Singh

Company Sec. & Compli. Officer : Chetna Anand

Whole Time Director & CEO : Aryan Goyal

Registered Office: 101 Gala Number Udyog Bhavan, I Flr Sonawala Lane Goregaon(E,Mumbai,Maharashtra-400063 Ph:

Email:cs@nureca.com

URL:http://www.nureca.com